Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
14.04
+0.42 (3.08%)
At close: Oct 29, 2025, 4:00 PM EDT
13.81
-0.23 (-1.64%)
After-hours: Oct 29, 2025, 4:49 PM EDT
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $380.16 million as of October 29, 2025. Its market cap has increased by 4.15% in one year.
Market Cap
380.16M
Enterprise Value
257.88M
1-Year Change
4.15%
Ranking
Category
Stock Price
$14.04
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has decreased from $528.69M to $380.16M, a decrease of -28.09%. That is a compound annual growth rate of -17.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 368.78M | 223.26% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 239.27B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |